INOVIO Pharmaceuticals
NEWS ALERT

FDA Accepts for Review INOVIO’s BLA for INO-3107 for the Treatment of Adults with Recurrent Respiratory Papillomatosis (RRP)

Press Releases

INOVIO to Report Second Quarter 2025 Financial Results on August 12, 2025

Posted on August 4, 2025

INOVIO Reports First Quarter 2025 Financial Results and Recent Business Highlights

Posted on July 30, 2025

INOVIO Announces Proposed Public Offering

Posted on July 30, 2025

INOVIO Announces Pricing of $25 Million Public Offering

Posted on July 30, 2025

INOVIO to Present at Upcoming Scientific Conference

Posted on July 30, 2025

INOVIO to Report First Quarter 2025 Financial Results on May 13, 2025

Posted on July 26, 2025

INOVIO to Present at Upcoming Scientific and Investor Conferences

Posted on July 26, 2025

INOVIO Reports First Quarter 2025 Financial Results and Recent Business Highlights

Posted on July 26, 2025

INOVIO Announces Proposed Public Offering

Posted on July 26, 2025

INOVIO Announces Pricing of $25 Million Public Offering

Posted on July 26, 2025

SUBSCRIBE FOR UPDATES FROM INOVIO
Register to receive email alerts for INOVIO press releases

© Copyright 2026 INOVIO Pharmaceuticals. All rights reserved.